Janssen in new research collaboration with Monash

Latest News

A new multi-year research collaboration between Janssen and Monash University that will focus on the immune mechanisms underpinning Coeliac Disease and support the development of new methods of diagnosis and treatment.

The research will be led by Professor Jamie Rossjohn from the Monash Biomedicine Discovery Institute.

Coeliac Disease is a serious health condition affecting approximately 1 per cent of the world’s population. It occurs when dietary gluten triggers a damaging immune response that attacks the body.

Monash University deputy vice-vhancellor (enterprise), Professor Ken Sloan, said the research agreement with Janssen is another example of Monash actively engaging with industry to explore new avenues.

“Monash University remains committed to moving research forward for the betterment of human health, creating new avenues and opportunities that may lead to tangible benefits for the broader community,” said Professor Sloan.

Director of the Monash Biomedicine Discovery Institute, Professor John Carroll, said the collaboration brings together leading researchers and industry partners to tackle this major health issue that affects so many individuals around the world.

“This collaboration is another example of how Monash BDI’s strong clinical relationships and industry engagement aim to accelerate the development of diagnostic and preventative treatments,” Professor Carroll said.

According to Kathy Connell, senior director of new ventures at Johnson & Johnson Innovation.

“Johnson & Johnson seeks to positively impact human health through innovation. We do this by helping researchers and entrepreneurs realize their dreams of creating healthcare solutions that improve peoples’ lives around the world.

"While the COVID19 global pandemic has, for now, disrupted some of the ways in which we connect with our collaborators around the world, Johnson & Johnson’s core commitment to sourcing the best science and partnerships globally remains. We are utilising a range of platforms to ensure we continue to engage meaningfully with Australian researchers and entrepreneurs as well as supporting their global networking needs.

Johnson & Johnson will continue to work side-by-side with innovators throughout their journey, providing a robust exchange of ideas and resources to support their success. This latest collaboration with Professor Jamie Rossjohn and his team at Monash University is an example of this global commitment.”